✦ LIBER ✦

Rifampicin Poxvirus and Trachoma Agent: Rifampicin Inhibition of Trachoma Agent in vivo

✍ Scribed by BECKER, YECHIEL; ASHER, YAEL; HIMMEL, NEHAMA; ZAKAY-RONES, ZICHRIYA; MAYTHAR, BATHIA

Book ID: 109669059
Publisher: Nature Publishing Group
Year: 1969
Tongue: English
Weight: 246 KB
Volume: 224
Category: Article
ISSN: 0028-0836
DOI: 10.1038/224033a0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rifampicin Poxvirus and Trachoma Agent:

Rifampicin Poxvirus and Trachoma Agent: Rifampicin and Poxvirus Replication

✍ BEN-ISHAI, ZVI; HELLER, EMMANUEL; GOLDBLUM, NATAN; BECKER, YECHIEL 📂 Article 📅 1969 🏛 Nature Publishing Group 🌐 English ⚖ 400 KB

Growth and Neutralization of the Trachom

Growth and Neutralization of the Trachoma Agent In Mouse Lungs

✍ GRAHAM, DORIS M. 📂 Article 📅 1965 🏛 Nature Publishing Group 🌐 English ⚖ 227 KB

Selective inhibition of oncogenic ras-p2

Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents

✍ Shazia Amar; Albert Glozman; Denise Chung; Victor Adler; Zeev Ronai; Fred K. Fri 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 189 KB

Effect of glutathione depletion on the i

Effect of glutathione depletion on the in vivo inhibition of drug metabolism by agents forming an inactive cytochrome P-450 Fe(II):Metabolite complex. Studies with amiodarone and troleandomycin

✍ Craig K. Svensson; Robert K. Drobitch; Kevin A. Kloss 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

PTK787/ZK222584, a tyrosine kinase inhib

PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo

✍ Markus Rudin; Paul M. J. McSheehy; Peter R. Allegrini; Martin Rausch; Diana Baum 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

## Abstract Assessment of tumour vascularity may characterize malignancy as well as predict responsiveness to anti‐angiogenic therapy. Non‐invasive measurement of tumour perfusion and blood vessel permeability assessed as the transfer constant, __K__^trans^, can be provided by dynamic contrast‐enha